Cis-element dependence and occupancy of the human invariant chain promoter in CIITA-dependent and -independent transcription

Molecular Immunology

Volumn 36, Issue 7, 1999, Pages 447-460

  Tai, Albert K F ^a   Zhou, Gang ^a   Chau, Kai Yin ^a   Ono, Santa Jeremy ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

CIITA; In vivo footprinting; Invariant chain gene expression; NF B; X box

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE; PROTEIN SUBUNIT; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ALPHA CHAIN; ARTICLE; B LYMPHOCYTE; BETA CHAIN; DELETION MUTANT; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; GENETIC TRANSCRIPTION; GENOME IMPRINTING; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSACTIVATION;

ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BASE SEQUENCE; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; ENHANCER ELEMENTS (GENETICS); GENE DELETION; GENES, REPORTER; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0032765782     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00061-9     Document Type: Article

References (39)

1. Abdulkadir S.A., Casolaro V., Tai A.K., Thanos D., Ono S.J. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains. J. Leukoc. Biol. 64:(5):1998;681-691.
2. Abdulkadir S.A., Krishna S., Thanos D., Maniatis T., Strominger J.L., Ono S.J. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression. J. Exp. Med. 182:(2):1995;487-500.
3. Abdulkadir S.A., Ono S.J. How are class II MHC genes turned on and off? FASEB J. 9:(14):1995;1429-1435.
4. Accolla R.S. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J. Exp. Med. 157:(3):1983;1053-1058.
5. Benichou B., Strominger J.L. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci., USA. 88:(10):1991;4285-4288.
6. Brachet V., Raposo G., Amigorena S., Mellman I. Ii controls the transport of major histocompatibility class II molecules to and from lysosomes. J. Cell Biol. 137:1997;51-55.
7. Boss J.M. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:(1):1997;107-113.
8. Brown A.M., Barr C.L., Ting J.P. Sequences homologous to class II MHC W, X, and Y elements mediate constitutive and IFN-gamma-induced expression of human class II-associated invariant chain gene. J. Immunol. 146:(9):1991;3183-3189.
9. Brown A.M., Linhoff M.W., Stein B., Wright K.L., Baldwin A.S. Jr, Basta P.V., Ting J.P. Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chainpromoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits. Mol. Cell Biol. 14:(5):1994;2926-2935.
10. Brown A.M., Wright K.L., Ting J.P. Human major histocompatibility complex class II-associated invariant chain gene promoter. Functional analysis and in vivo protein/DNA interactions of constitutive and IFN-gamma-induced expression. Biol. Chem. 268:(35):1993;26328-26333.
11. Chang C.H., Guerder S., Hong S.C., van Ewijk W., Flavell R.A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 4:(2):1996;167-178.
12. Chang C.H., Flavell R.A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:(2):1995;765-767.
13. Chapman H.A. Endosomal proteolysis and MHC class II function. Curr. Opin. Immunol. 10:1998;93-102.
14. Chin K.C., Mao C., Skinner C., Riley J.L., Wright K.L., Moreno C.S., Stark G.R., Boss J.M., Ting J.P. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity. 1:(8):1994;687-697.
15. Collins T., Korman A.J., Wake C.T., Boss J.M., Kappes D.J., Fiers W., Ault K.A., Gimbrone M.A. Jr, Strominger J.L., Pober J.S. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci., USA. 81:(15):1984;4917-4921.
16. Denzin L.K., Sant'Angelo D.B., Hammond C., Surman M.J., Cresswell P. Negative regulation by HLA-DO of MHC class II restricted antigen processing. Science. 278:1997;106-109.
17. Deussing J., Roth W., Saftig P., Peters C., Ploegh H.L., Villadangos J.A. Cathepsin B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Acad. Sci., USA. 95:1998;4516-4521.
18. Doyle C., Ford P.J., Ponath P.D., Spies T., Strominger J.L. Regulation of the class II-associated invariant chain gene in normal and mutant B lymphocytes. Proc. Natl. Acad. Sci., USA. 87:(12):1990;4590-4594.
19. Kim T.K., Kim T.H., Maniatis T. Efficient recruitment of TFIIB and CBP-RNA polymerase II holoenzyme by an interferon-beta enhanceosome in vitro. Proc. Natl. Acad. Sci., USA. 95:(21):1998;12191-12196.
20. Kleijmeer M.J., Morkowski S., Griffith J.M., Rudensky A.Y., Geuze H.J. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J. Cell Biol. 139:1997;639-649.
21. Kolk D.P., Floyd-Smith G. Induction of the murine class-II antigen-associated invariant chain by TNF-alpha is controlled by an NF-kappa B-like element. Gene. 126:(2):1993;179-185.
22. Korman A.J., Boss J.M., Spies T., Sorrentino R., Okada K., Strominger J.L. Genetic complexity and expression of human class II histocompatibility antigens. Immunol. Rev. 85:1985;45-86.
23. Lanzavecchia A., Reid P.A., Watts C. Irreversible association of peptides with class II MHC molecules in living cells. Nature. 357:1992;249-252.
24. Levine F., Erlich H.A., Mach B., Pious D. Transcriptional regulation of HLA class II and invariant chain genes. J. Immunol. 134:(1):1985;637-640.
25. Linhoff M.W., Wright K.L., Ting J.P. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model. Mol. Cell Biol. 17:(8):1997;4589-4596.
26. Mach B., Steimle V., Martinez-Soria E., Reith W. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:1996;301-331.
27. Ono S.J., Bazil V., Sugawara M., Strominger J.L. An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP. J. Exp. Med. 173:(3):1991;629-637.
28. Ono S.J., Song Z. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box. J. Biol. Chem. 270:(11):1995;6396-6402.
29. Paulnock-King D., Sizer K.C., Freund Y.R., Jones P.P., Parnes J.R. Coordinate induction of Ia alpha, beta, and Ii mRNA in a macrophage cell line. J. Immunol. 135:(1):1985;632-636.
30. Pessara U., Momburg F., Koch N. Cooperative effect of interferon-gamma and tumor necrosis factor-alpha on the induction of the class II antigen-associated invariant chain expression. Eur. J. Immunol. 18:(11):1988;1719-1726.
31. Riberdy J.M., Newcomb J.R., Surman M.J., Barbosa J.A., Cresswell P. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature. 360:(6403):1992;474-477.
32. Sartoris S., Valle M.T., Barbaro A.L., Tosi G., Cestari T., D'Agostino A., Megiovanni A.M., Manca F., Accolla R.S. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity. J. Immunol. 161:(2):1998;814-820.
33. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 265:(5168):1994;106-109.
34. Song Z., Krishna S., Thanos D., Strominger J.L., Ono S.J. A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressor. J. Exp. Med. 180:(5):1994;1763-1774.
35. Sung E., Jones P.P. The invariant chain of murine Ia antigens: its glycosylation, abundance and subcellular localization. Mol. Immunol. 18:(10):1981;899-913.
36. Thanos D., Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell. 83:(7):1995;1091-10100.
37. Wright K.L., Chin K.C., Linhoff M., Skinner C., Brown J.A., Boss J.M., Stark G.R., Ting J.P. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc. Natl. Acad. Sci., USA. 95:(11):1998;6267-6272.
38. Wright K.L., Moore T.L., Vilen B.J., Brown A.M., Ting J.P. Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y. J. Biol. Chem. 270:(36):1995;20978-20986.
39. Zhou H., Su H.S., Zhang X., Douhan J. III, Glimcher L.H. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant. J. Immunol. 158:(10):1997;4741-4749.